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Structure of GrlR–GrlA complex that prevents
GrlA activation of virulence genes
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Yu Keung Mok1, Ilan Rosenshine2 & J. Sivaraman1
The locus of enterocyte effacement (LEE) is essential for virulence of enterohaemorrhagic
Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC). The 41 genes of the LEE encode
type III secretion system proteins and three associated regulators: Ler, GrlA and GrlR. Ler is a
positive regulator for most of the LEE operons, including grlRA. GrlA controls the expression
of ler, ehxCABD and flhDC operons. GrlR binds to GrlA and suppresses its function. Here we
report the crystal structure of GrlR–GrlAD (aa 1–106) complex (2:1) and its functional
characterization. We show that GrlR interacts with the Helix-Turn-Helix motif of GrlA.
Moreover, GrlA binds to the promoter DNA fragments of ler, ehxCABD and flhDC, and GrlR
outcompetes with these promoter DNA sequences for the Helix-Turn-Helix motif of GrlA.
These findings provide mechanistic insight into a regulatory module for the virulence of EPEC
and EHEC, two important pathogens that cause devastating diseases.
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A
ttaching and effacing (AE) pathogens comprise a group of
enteric pathogens, including the closely related enter-
ohaemorrhagic Escherichia coli (EHEC) and enteropatho-
genic E. coli (EPEC). EPEC causes severe diarrhea in young
children, whereas EHEC is a causative agent of haemorrhagic
colitis and haemolytic uremic syndrome1,2. AE pathogens possess
type III secretion systems (T3SS) that promote virulence. Most
T3SS components and related proteins are encoded by genes in
the locus of enterocyte effacement (LEE). The LEE consists of 41
genes, clustered in 5 different operons, termed LEE1–LEE5, and
some additional transcription units3.
Under specific conditions, such as low temperature, the histone-
like nucleoid-structuring (H-NS) protein binds to extended
regions within the LEE DNA and silences the expression of the
entire LEE region. This H-NS-mediated repression, however, can
be countered by Ler (LEE-encoded regulator), a protein encoded
by the first gene in the LEE1 operon that functions as a positive
regulator of other LEE operons (LEE2–LEE5)4. Moreover, Ler is
involved in both the direct and indirect regulation of additional
key virulence components of EPEC and EHEC, and is thus
considered as the master regulator of the virulence machineries of
these pathogens. Accordingly, activation of LEE1 and ler
expression is a key event in the activation of the entire virulence
system of EPEC and EHEC. It is therefore not surprising that the
LEE1 promoter is subjected to tight regulation by multiple factors
(Fig. 1), including H-NS and Ler, which function as repressor and
autorepressor, respectively. The expression of the LEE1 operon is
strictly dependent on binding of the integration host factor protein
immediately upstream to the LEE1 promoter4, and activation of
LEE1 expression is promoted by two redundant positive
regulators, PerC5 (or Pch in EHEC) and GrlA.
The grlR and grlA genes form a transcriptional unit encoding
GrlR and GrlA, respectively. GrlA is a positive regulator of the
LEE1 promoter and forms a positive regulatory loop with Ler.
GrlR binds to GrlA and this is thought to account for the
negative effect of GrlR on ler expression3,4,6. As GrlA and GrlR
are co-expressed, it is expected that, in most cases, GrlA is
inhibited by GrlR and that the relative levels of GrlR and GrlA are
regulated. For instance, it was reported that under certain
conditions GrlR is degraded by the ClpXP protease, freeing GrlA
to activate Ler expression7.
Previously, we reported the structure of GrlR and elucidated its
role in LEE regulation8,9. GrlR forms a stable and tight dimer in
solution as well as in the crystal. The dimeric architecture of GrlR
is maintained by the cluster of hydrophobic interactions as well as
numerous hydrogen-bonding contacts at the dimeric interface8.
GrlA has also been functionally characterized3,4,10, but no
structural information is available to provide insight into the
regulatory mechanisms involving GrlA, GrlR and Ler.
In addition to its function as a LEE1 regulator, GrlA negatively
regulates the transcription of the flhDC operon and thus controls
flagellar gene expression. Kitagawa et al.11 demonstrated that
flagellar gene expression in EHEC was strictly regulated by
dual pathways: (i) post-translational control of the FlhD/C
master regulator by ClpXP-mediated protein degradation and
(ii) transcriptional control of the flhDC operon through the GrlR–
GrlA system under LEE-inducing conditions. Moreover, deletion
of grlR results in a non-motile phenotype in the EHEC O157
Sakai strain6. In many pathogens, motility is repressed by
negatively regulating flhDC concomitant with T3SS induction11.
GrlA-dependent repression of flagellar regulation is important for
efficient adhesion of EHEC to host cells6,11 and perhaps also to
avoid detection by the host innate immune sensors TLR5 and
NLRP4 (refs 12,13). GrlA is also implicated in the transcriptional
activation of the ehxCABD operon in EHEC14,15. The ehxA gene
encodes haemolysin, and ehxC acts as a modifying factor that
converts inactive haemolysin into its active form by the addition
of a fatty acid group16; the specific secretion machinery for EhxA
is encoded by ehxB and ehxD17.
The in vitro instability of GrlA has previously hindered
structural studies and other attempts to elucidate the regulatory
mechanism involving Ler, GrlA and GrlR. Here we report
the crystal structure of GrlAD (aa1–106) in complex with
GrlR, refined up to 2.7 Å resolution, and the associated
functional studies. The structure is asymmetric with a stoichio-
metry of 2 GrlR:1GrlAD. In addition, we identify a novel regu-
latory mechanism by which GrlR interacts with GrlA at its
Helix-Turn-Helix (HTH) motif, preventing GrlA from binding to
its target promoter DNA.
Results
Overall structure of the GrlR–GrlAD complex. We initially
attempted to determine the structure of full-length GrlA in
complex with GrlR. However, the full-length GrlR–GrlA complex
did not yield diffraction quality crystals, presumably because of
the unstable nature of GrlA. As a result, we generated GrlR–GrlA
complexes with varying lengths of GrlA. A complex of GrlR with
GrlAD (aa1–106) (Fig. 2a) yielded diffraction quality crystals.
The structure was determined and refined up to 2.7 Å resolution
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Figure 1 | Schematic of the regulatory circuits related to the GrlR–GrlA
complex. We propose the following model based on results presented in
this report as well as results previously published by others and by us. The
grlR and grlA genes form a bicistronic operon located within the LEE. Under
non-inducing conditions, the expression of the entire LEE, including grlRA, is
suppressed by a H-NS protein, and the activity of the residual GrlA is
suppressed by GrlR via direct interaction (repression is indicated by red
lines). The expression of the entire system can be activated by two
alternative modes. The first involves specific environmental cues that turn
on PerC expression; this, in turn, activates the expression of ler (activation is
indicated by blue lines). Ler then antagonizes H-NS and stimulates the
expression of all of the other LEE operon components, including grlRA. The
produced GrlA directly activates ler expression to establish the GrlA-Ler-
positive feedback loop. Consequently, GrlA indirectly promotes the
expression of all LEE genes, directly activates the expression of the ehx
operon, and represses the expression of the flagella master regulator flhDC.
The GrlA-Ler loop is restrained by the autorepressive action of Ler as well
as by GrlR, which directly binds to GrlA to inhibit its interaction with target
DNA. The second mode of activation involves environmental signals that
trigger the ClpXP protease to degrade GrlR, thus releasing GrlA to activate
ler expression and mediate the establishment of the Ler-GrlA-positive loop
described above.
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(Table 1 and Fig. 2b). The first 8 residues and last 11 residues of
GrlAD were not well-defined in the electron density map and
were not included in the model. GrlR is a b-barrel protein,
structurally similar to our previously determined GrlR structures
(root mean squared deviation (r.m.s.d.) of 0.87Å for all Ca
atoms)8,9, whereas GrlAD mainly comprises a HTH motif
(aa 39–66) and an anti-parallel b-sheet in the carboxy terminus
(Fig. 2c,d). The complex consists of one dimer of GrlR bound to a
monomer of GrlAD (2:1 stoichiometric ratio), with 15 hydrogen-
bonding contacts (o3.2 Å) formed between GrlR and GrlAD, and
a buried area of 1,043.8Å (ref. 2). This GrlR:GrlA stoichiometric
ratio was further verified by analytical ultracentrifugation, which
showed that the complex is of 47.3 kDa, corresponding to two
molecules of 6His-GrlR and one molecule of GrlA (Fig. 2e). This
is consistent with the gel filtration experiment (Supplementary
Fig. S1a,b).
Sequence and structural homology of GrlA. GrlA homologues
are present in over 100 species of bacteria, including EPEC,
EHEC, Citrobacter rodentium, Shigella sp. and Salmonella sp.
with no structures available to date. GrlA shares 33% sequence
identity (46% similarity) with CaiF, a potential transcriptional
activator of carnitine metabolism in E. coli, and belongs to the
PFAM family of DUF1401 (http://pfam.sanger.ac.uk/family/
DUF1401). Despite a very low sequence identity (o7%), the
DALI18 search for structural homologues of GrlA identified
several regulatory proteins. The closest homologues are also HTH
motif-containing proteins, such as a transcriptional regulator
from Methanosarcina mazei (PDB 3R0A; r.m.s.d. 2.8 Å for 72 Ca
atoms), a DNA-binding protein from Pyrococcus horikoshii OT3
(PDB 1ULY; r.m.s.d. 2.5 Å for 67 Ca atoms) and a double-
stranded RNA-specific adenosine deaminase (PDB 3F23; r.m.s.d.
2.6 Å for 61 Ca atoms). These structural similarities suggest that
these homologues may have similar functions, such as in
transcriptional regulation.
GrlR interacts with the HTH and C-terminal regions of GrlA.
The crystal structure of the complex revealed that GrlR interacts
with the HTH motif region of GrlAD (Fig. 3a,b and
Supplementary Fig. S2a,b). The residues R53, R54, R64, R65 and
K66 from the HTH region of GrlAD are involved in hydrogen-
bonding contacts with GrlR. Our previous studies with GrlA8
suggested that the C-terminal region of GrlA might
be involved in binding to GrlR (please refer to the Discussion
section). Therefore, we sought to independently verify the
contribution of the amino-terminal HTH motif and the
C terminus of GrlA in its interaction with GrlR. To verify this,
we created three constructs by substituting the abovementioned
five interacting amino acids of the HTH motif region with alanine
(denoted as GrlA5M), truncating the C-terminal region of GrlA
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Figure 2 | Structure of the GrlR–GrlAD heterotrimeric complex. (a) GrlR and GrlA proteins with motifs. (b) Crystal structure of the GrlR–GrlAD complex.
The two monomers of GrlR are shown in green (monomer A) and cyan (monomer B). GrlAD is shown in magenta. The ligand Triton X-100 is shown
as sticks. (c) Structure of GrlAD. (d) The topology diagram of the GrlAD molecule. Structure-related figures are prepared using PyMol35. (e) The
stoichiometric ratio of WT GrlR–GrlA complex protein was investigated in an analytical ultracentrifuge by monitoring their sedimentation properties
in a sedimentation velocity experiment. The peak corresponds to a molecular weight of 47.3 kDa, indicating the presence of two molecules of 6His-GrlR and
one molecule of GrlA in the complex.
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(GrlAD), or both mutations (GrlAD5M). Thus, the various GrlA
constructs used in these interaction studies include MBP-GrlA,
MBP-GrlA5M, MBP-GrlAD and MBP-GrlAD5M. The circular
dichroism spectrum of the wild type (WT) and mutants of GrlA
suggest that the mutants have the same fold as the WT GrlA
(Supplementary Fig. S3).
The Kd for the interaction between GrlR and MBP-GrlA was
determined by isothermal titration calorimetry (ITC). GrlR
interacts with MBP-GrlA with an B35-fold higher affinity
(Kd¼ 0.031mM) than with MBP-GrlAD (Kd¼ 1.1mM) (Fig. 4a
and Supplementary Table S1). Similarly, the Kd for the interaction
between GrlR and MBP-GrlA5M was also higher (Kd¼ 0.96mM)
than the WT interaction (Fig. 4b and Supplementary Table S1).
Besides the 35- and 31-fold reductions in affinity, respectively,
MBP-GrlAD and MBP-GrlA5M also showed thermodynamic
profiles distinct from the WTMBP-GrlA. Although the MBP-GrlA
interaction with GrlR is enthalpically and entropically favourable
(DH¼  4.8 kcalmol 1 and TDS¼  5.4 kcalmol 1), the
other two protein variants (GrlAD and GrlA5M) showed an
enthalpically driven interaction, with unfavourable entropic contri-
butions (DH¼  21.0 kcalmol 1 and TDS¼ 12.9 kcalmol 1,
for MBP-GrlAD; DH¼  9.6 kcalmol 1 and TDS¼
1.3 kcalmol 1, for GrlA5M; Supplementary Table S1).
GrlR interacted with the WT MBP-GrlA or MBP-GrlAD with a
stoichiometric ratio of 2:1. However, the stoichiometric ratio
between GrlR and MBP-GrlA5M was 1:1, which suggests that two
MBP-GrlA5M molecules bind with a dimeric GrlR
(Supplementary Table S1). The MBP-GrlAD5M construct did
not show binding to GrlR.
Subsequently, we examined the role of each of the aforemen-
tioned key residues in mediating the interaction between GrlR and
GrlA by pull-down assay. MBP-GrlAD containing double amino
acid substitutions (MBP-GrlAD (R53A R54A), MBP-GrlAD
(R64A R65A) and MBP-GrlAD (R65A K66A)) did not interact
with GrlR (Fig. 5a and Supplementary Figs S4a,b and S5a),
whereas single alanine substitutions had little effect on the GrlAD–
GrlR interaction (Supplementary Fig. S5b). Consistent with the
ITC results, MBP-GrlA, MBP-GrlAD and MBP-GrlA5M pulled
down GrlR, whereas MBP-GrlAD5M did not (Supplementary Fig.
S5c). We further verified the role of the key residues of GrlR in
mediating GrlA binding, which shows that alanine substitution at
D35 and E60 of GrlR could abolish its binding to MBP-GrlAD
(Fig. 5b and Supplementary Fig. S5d). Moreover, these results
were confirmed using a pETDuet-1-grlR-grlAD co-expression and
co-purification system with 6His tag on GrlR and a tagless GrlAD
(Supplementary Figs S6a,b, S7 and S8). Taken together, these
results show that GrlR–GrlA interaction involves both the HTH
motif region and the C-terminal region of GrlA.
ler Promoter region and GrlR compete for HTH motif of GrlA.
Previous studies demonstrated that GrlA binds to DNA via its
HTH motif10, and the crystal structure of the GrlR–GrlAD
complex revealed that GrlR interacts with the HTH motif region
of GrlAD (Fig. 3a,b and Supplementary Fig. S2a,b). On the basis
Table 1 | Crystallographic statistics and refinement details.
SelMet SAD
Data collection
Space group C2221
Cell dimensions
a, b, c (Å) a¼83.19, b¼ 121.21, c¼ 84.83
a, b, g () 90
Wavelength 0.97893
Resolution (Å) 50.0–2.62(2.67–2.62)
aRsym or Rmerge 0.12 (0.39)
I/sI 16.23 (3.56)
Completeness (%) 98.0 (82.8)
Redundancy 13.9 (10.6)
Refinement
Resolution (Å) 15.0–2.7
No. of reflections 22,108
bRwork/
cRfree 0.18/0.23
No. of atoms
Protein 2,543
Ligand/ion 26
Water 15
B-factors
Protein 53.9
Ligand/ion 54.80
Water 45.7
r.m.s.d.
Bond lengths (Å) 0.01
Bond angles () 1.283
r.m.s.d., root mean squared deviation; SAD, single-wavelength anomalous dispersion.
aRsym¼S|Ii oI4|/S|Ii| where Ii is the intensity of the ith measurement, andoI4 is the mean
intensity for that reflection.
bRwork¼S|Fobs Fcalc|/S|Fobs| where Fcalc and Fobs are the calculated and observed structure
factor amplitudes, respectively.
cRfree¼ as for Rwork, but for 10.0% of the total reflections chosen at random and omitted from
refinement. Individual B-factor refinement was carried out.
*Values in the parenthesis are the highest resolution bin values.
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Figure 3 | Structure of the GrlR–GrlAD interacting surface. (a) The GrlR dimer is shown in surface representation and GrlAD is shown as a cartoon. The
interacting residues of GrlAD are shown as sticks. (b) Final 2Fo-Fc electron density map (contoured at 1s) for the key residues of GrlAD.
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of these observations, we proposed that promoter DNA and GrlR
would compete for the HTH motif region of GrlA. To test this
prediction, we adopted a structure-guided alanine substitution
analysis created in the HTH motif region of full-length MBP-
GrlA at the following positions: R53, R54, R64, R65 and K66 of
the HTH motif and Y78. Electrophoretic mobility shift assays
(EMSAs) were performed to study the interaction of the GrlA
mutants with a DNA fragment containing the ler promoter and
regulatory regions (Fig. 6a,b). Mutants with single alanine sub-
stitutions at R53, R54, R65 and K66 exhibited mobility shifts that
were less than that observed for the WT GrlA, indicating a
reduced affinity for DNA. The MBP-GrlA R64A mutant and a
double mutant of MBP-GrlA (R65A K66A) failed to interact
with DNA (Fig. 6b, lanes 4 and 8). Furthermore, the Y78A
mutant formed a shifted complex that was comparable to the WT
GrlA–DNA complex (Fig. 6b, lane 7).
To determine whether the addition of GrlR could dissociate
MBP-GrlA from the ler promoter, a competitive EMSA assay was
carried out (Fig. 6c). Under the given experimental conditions,
when the concentration of GrlR was increased to 0.3 mM, the
MBP-GrlA–DNA complex dissociated. No mobility shift of the
DNA was detected at higher GrlR concentrations (40.3 mM). To
verify the formation of the GrlR–GrlA complex, a preformed
MBP-GrlA–DNA complex bound to amylose beads was titrated
against GrlR and washed with DNA-binding buffer. Beads from
each of these stages and washes were simultaneously analysed
using SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and
EMSA assay. The EMSA gel analysis showed no apparent shift in
the DNA as compared with DNA alone after the MBP-GrlA–
DNA complex was titrated with GrlR (Supplementary Fig. S9a,
lane 6). SDS–PAGE analysis showed bands corresponding to
MBP-GrlA and GrlR in the final beads (Supplementary Fig. S9b,
lane 9). These results indicate that DNA bound to MBP-GrlA was
replaced by GrlR. Besides, these findings show that GrlR
outcompetes with DNA to bind to the GrlA HTH motif.
Next, we sought to verify the ability of DNA to pull out GrlA
from the GrlR–GrlA complex. A preformed GrlA–GrlR complex
was incubated with increasing concentrations of DNA (Pler) for
about 30min and then analysed using EMSA assay. There was no
apparent shift in the DNA incubated with preformed GrlA–GrlR
complex compared with the control DNA fragment
(Supplementary Fig. S10). These results clearly show the inability
of DNA to displace GrlR from the GrlR–GrlA complex.
The GrlR–GrlAD complex is functional in vivo. We next
determined whether the GrlAD could form a functional reg-
ulatory complex with DNA in vivo. To this end, we employed
the EPEC-null strain (DgrlRA::kn), which contains a ler-gfp
transcriptional fusion (GY2155), and for which the green
fluorescent protein (GFP) expression levels report the activity of
the ler promoter. This strain was transformed with a plasmid
expressing GrlA or GrlAD, and the GFP levels were compared
by western blot analysis using an antibody directed against GFP.
The results show that the activity of the ler promoter in the
strain expressing the full-length GrlA and GrlAD is almost the
same, indicating that GrlAD is functional in vivo (Fig.7a and
Supplementary Fig. S11a). This finding also suggests a negligible
role of the last 31 amino acids of GrlA in terms of ler promoter
binding. The strain expressing both GrlR and GrlA showed less
activity as compared with the strain expressing GrlA alone,
illustrating the repressive activity of GrlR. Repression by GrlR in
the GrlAD-expressing strain was comparable with that expres-
sing both GrlR and full-length GrlA (Fig.7a and Supplementary
Fig. S11a).
An additional readout for the functionality of GrlAD is the
secretion of EspB, which reflects ler expression and function-
ality19. EspB is a major T3SS effector protein and EspB secretion
acts as an indicator for the formation of a functional T3SS20. Our
measurements of EspB secretion is in agreement with the data
obtained with the ler-gfp promoter assay. The secretion assay
showed comparable EspB secretion between DgrlRA::kn-null
strains supplemented with a plasmid expressing either GrlAD
or full-length GrlA (Fig. 7b and Supplementary Fig. S11b).
Similarly, a comparable amount of EspB was secreted from the
mutant expressing GrlRA or GrlRAD. Although deletion of the
C-terminal region of GrlA resulted in a substantial decrease in the
affinity between GrlA and GrlR (Fig. 4a), we did not observe
significant phenotypic consequences under the experimental
conditions used in this study (Fig. 7a,b and Supplementary
Fig. S11a,b). This suggests that as long as the N-terminal region of
GrlA is intact, the protein remains functional. The role of the
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Figure 4 | Role of the C-terminal region and the HTH motif region of
GrlA in GrlR–GrlA interactions. (a) The binding affinities of MBP-GrlA/
MBP-GrlAD to GrlR were determined using ITC. Representative ITC profiles
are shown. The GrlA proteins used are indicated above each panel. The
upper part of each panel shows the thermogram (thermal power versus
time) after baseline correction and the bottom part of each panel shows the
binding isotherm (normalized heat versus molar ratio of reactants) for each
injection. The solid lines in the bottom part of each panel show the fit
of the data to a function based on a single class of binding site model.
(b) The binding affinities of GrlR to MBP-GrlA/MBP-GrlAD with
substitutions in the HTH motif region (5M) were determined using ITC
(5M refers to substitutions at R53A, R54A, R64A, R65A and K66A). The
binding constants (Ka and Kd), number of binding sites (N), enthalpy (DH)
and entropy (DS) are provided in Supplementary Table S1.
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additional interaction from the C-terminal region of GrlA thus
remains to be identified.
The key HTH residues are required for GrlA function in vivo.
EspB secretion was further used to examine the role of the key
HTH residues in the regulatory functions of GrlA. To eliminate
the negative regulatory effect of GrlR, we transformed the
DgrlRA::kn-null strain with a plasmid expressing GrlAD. Bacteria
were grown under conditions that favoured positive regulation of
the T3SS by GrlA5, and the amount of EspB secretion was
determined by western blot analysis (Fig. 8a and Supplementary
Fig. S11c). Secretion of EspB was elevated when the DgrlRA::kn-
null strain was supplemented with GrlAD, and GrlA with alanine
substitutions at R65 or K66 induced efficient EspB secretion
(Fig. 8a and Supplementary Fig. S11c). In contrast, the GrlAD
R64A mutant failed to induce EspB secretion (Fig. 8a and
Supplementary Fig. S11c) as did the GrlAD (R65A K66A) double
mutant. Taken together, the results show that substitutions in key
residues in the GrlA HTH region, which hamper binding to the
ler regulatory region, elicit a profound effect on the ability of the
bacteria to assemble a functional T3SS and thus on the bacterial
virulence. These effects are presumably related to reduced activity
of the ler promoter and consequently reduced expression of some
or all of the LEE operons.
To more directly test the role of HTH key residues in the
activation of the ler promoter, we employed the ler-gfp promoter
assay described above (Fig. 8b and Supplementary Fig. S11d). The
EPEC-null strain (DgrlRA::kn), which contains a ler-gfp trans-
criptional fusion (GY2155), was transformed with a plasmid
expressing various grlA mutants. Substitutions such as R65A and
K66A were well tolerated, unlike R54A and R64A, where the
activity of the ler promoter was reduced substantially. The results
from both the secretion assay and the ler-gfp promoter assays
were thus consistent, validating the importance of the key
residues in the HTH motif in mediating the function of GrlA as a
positive regulator of ler and subsequently as positive regulator of
the T3SS biogenesis.
GrlR competes with flhDC and ehxCABD operons for GrlA
binding. We next examined whether the competition between the
ler promoter region and GrlR for binding to GrlA was unique to
the ler regulatory region or a more general mode of operation of
the GrlR–GrlA system. To this end, we examined two additional
GrlA targets: the flhDC and ehxCABD promoter regions11,14,15.
We performed EMSA assays by incubating MBP-GrlA with a
DNA fragment containing the flhDC promoter region. The
addition of GrlA shifted the DNA, indicating that MBP-GrlA had
bound to the promoter region of the flhDC operon
(Supplementary Fig. S12a). The HTH mutants that were pre-
viously shown to alter GrlA binding to the ler regulatory region
showed a similar pattern of binding to the flhDC regulatory
region (Supplementary Fig. S12b). A competitive EMSA assay
also indicated that the addition of GrlR clearly reduced the
interaction of GrlA with the flhDC regulatory region, presumably
by binding to GrlA and displacing the DNA (Supplementary
Fig. S13).
With respect to the ehxCABD operon, EMSA assays showed
that MBP-GrlA specifically binds to the ehx promoter region.
Subsequent EMSA experiments using mutant MBP-GrlA showed
various amounts of reduction in the mobility shifts, consistent
with those seen for GrlA binding to ler and flhDC promoter
regions (Supplementary Figs S14a–c and S15). Cumulatively, our
findings suggest that the general mode of operation of the GrlR–
GrlA system involves mutually exclusive binding of the GrlA
HTH motif with either GrlR or its target DNA.
Discussion
Extensive functional analyses have shown that the GrlR–GrlA is a
key regulatory complex involved in the direct or indirect
regulation of most virulence genes in AE pathogens, including
EPEC, EHEC and C. rodentium3,4,6,8. These studies include
demonstration of the regulatory role of the GrlR–GrlA system in
three independent operons: LEE1, flhDC and ehxCABD4,11,21.
GrlA positively regulates the expression of ler, the first gene in the
LEE1 operon, which in turn regulates the expression of various
downstream genes involved in T3SS biogenesis4. In addition to
LEE1, GrlA is also involved in the positive regulation of ehx
operons and the negative regulation of the flhDC operon (Fig. 1).
GrlR binds directly to GrlA and functions as an anti-regulator4.
However, the molecular details of the regulation of the GrlR–
GrlA complex have, until now, remained elusive because of the
lack of structural details. Here we close this gap, reporting the
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crystal structure of the GrlR–GrlAD complex, along with
supportive functional studies.
In a previous study, we reported the binding between GrlR and
GrlA mediated by the possible interaction of an 46EDED49 motif
of GrlR with the C-terminal region of GrlA8. However, we could
not confirm this finding in the present complex structure because
of the absence of the C-terminal region (aa107–137) of GrlA in
the crystallized construct, wherein the majority of GrlAD
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upstream and downstream from the functional ATG start codon,
respectively) DNA VBP is a non-specific DNA. (b) EMSA assay with
substituted MBP-GrlA proteins. PCR DNA fragments comprising the
regulatory region (ler 275/þ 217) were mixed and incubated with 1.0 mM
of purified MBP-GrlA, or with different substituted mutants. Free DNA and
protein–DNA complexes were resolved by 5% PAGE and stained with
ethidium bromide. The GrlA species used include: WT GrlA, GrlA R53A,
GrlA R54A, GrlA R64A, GrlA R65A, GrlA K66A, GrlA Y78A,
GrlAR65AK66A and ler pr (ler  275/217). (c) Competitive EMSA assay
aimed at testing competition between DNA and 6His-GrlR for binding to
MBP-GrlA. PCR DNA fragments comprising the regulatory region
(ler 275/þ 217) were mixed and incubated with 1 mM purified MBP-GrlA
for 15min, then combined with increasing concentrations (0.0, 0.15, 0.3,
0.45 and 0.6mM) of 6His-GrlR for an additional 15min. The complexes and
free DNA were separated on a 5% native polyacrylamide gel and stained
with ethidium bromide (ler pr: ler  275/þ 217).
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interactions occurs with one monomer of the dimeric GrlR.
Despite this, we were able to verify the binding of full-length GrlA
to GrlR using ITC and pull-down experiments (Fig. 4a,
Supplementary Fig. S5c and Supplementary Table. S1). The ITC
experiments indicated that full-length GrlA binds to GrlR with a
B35-fold higher affinity than GrlAD. These results suggest the
role of the GrlA C terminus in its interaction with GrlR. Despite
this difference in affinity, under the employed experimental
conditions, GrlAD exhibited an activity comparable to full-length
GrlA (Fig. 7a,b).
Previous studies of the GrlR–GrlA interaction were performed
with glutatione S-transferase-tagged proteins8,10. These studies
suggest that the glutathione S-transferase tag might interfere with
the interaction, and could be the reason for the complete
disruption of GrlA binding with GrlR following alanine
substitution in the 46EDED49 motif in our previous study8.
To avoid this potential pitfall, the current experiments were
carried out using MBP-tagged GrlA. We and others have
independently verified that MBP is not involved in the
GrlA–GrlR interaction10.
Here we show that substitutions in the HTH motif of GrlAD
interfered with GrlR binding, whereas the full-length GrlA with
substitutions in the HTH region was able to bind to GrlR
probably through its C-terminal region (Figs 4b and 5a,
Supplementary Fig. S5c; Supplementary Table S1). Jimenez
et al.10 show that GrlAD1 (aa1–100) was able to pull down
GrlR, and our observation of two binding sites agrees with this
finding. Thus, even though the binding site located to the GrlA C
terminus was deleted, these deletion constructs can still pull
down GrlR via this alternative binding site located at the HTH
region.
Our data shows that GrlR interacts with GrlA to prevent its
binding to target DNA. The fact that grlR and grlA are co-
transcribed raises the question that under what conditions GrlA
can escape suppression by GrlR and interact with its target DNA.
Given the tight GrlR–GrlA mode of interaction and the
observation that two GrlR molecules are to needed suppress
one GrlA molecule, it can be assumed that GrlA will function as a
regulator only when its steady-state level reaches more than half
of that for GrlR. The relative steady-state level of the two proteins
is controlled by their relative translation rates and stability.
Although virtually nothing is known about the first, it is expected
that the translation rate would be equal in generating both GrlR
bound, as well as free, GrlA. The differential stability and specific
GrlR degradation by ClpXP has been previously reported6. An
additional point of view on this system is that GrlR in complex
with GrlA stabilizes GrlA and maintains it in an inactive state that
can become functional and rapidly released following an
appropriate signal and ClpXP-mediated GrlR degradation.
In conclusion, the present study revealed the molecular
structure and mechanism of the GrlR–GrlA complex. GrlR and
the promoter regions of ler, flhDC and ehxCABD compete for the
HTH motif region of GrlA. GrlR outcompetes with these
promoter DNA sequences for GrlA. Regulation of multiple
virulence operons by a central heterotrimeric GrlR–GrlA complex
would help the pathogen to precisely control the expression of
various genes involved in its pathogenesis. By differentially
regulating the ler and ehx operons positively and the flhDC
operon negatively, GrlR and GrlA coordinate and optimize gene
expression by the pathogen during the infection process.
Methods
Plasmid and strain construction. Bacterial strains and plasmids used in this study
are listed in Supplementary Table S2. Intact grlR and grlA genes were PCR-
amplified from EHEC EDL933 (ref. 22) chromosomal DNA and cloned into MCS1
(with a 6His tag) and MCS2 of the pETDuet-1 (Novagen, Madison, WI, USA)
vector, respectively. Plasmid pET32-grlR was constructed by amplifying the grlR
gene from EHEC EDL933 chromosomal DNA and cloning into pET32 vector.
Plasmid pGEX-grlA and pMBP-grlA were constructed by amplifying the grlA DNA
fragments from EHEC EDL933 chromosomal DNA and cloning into pGEX-4T1
(GE Healthcare, Buckinghamshire, UK) and pMAL-c2X (New England Biolabs,
Ipswich, MA, USA), respectively. The EPEC grlRA-null mutant (DgrlRA::kn) was
constructed by replacing the grlRA gene from an EPEC strain with a kanamycin
cassette by the one-step method using the l-recombinase system23. Site-specific
mutations in grlA were introduced by overlapping PCR24, which uses
complementary oligodeoxyribonucleotide (oligo) primers and the PCR to generate
two DNA fragments having overlapping ends. These fragments are annealed,
allowing the 30-overlap of each strand to serve as a primer for the 30-extension of
the complementary strand. The resulting fusion product is amplified further by
PCR. Specific mutations in the nucleotide sequence were introduced by
incorporating nucleotide changes into the overlapping oligo primers. Each
construct was verified by DNA sequencing. To construct pGY1, a DNA fragment
containing PLEE1 and ler (starting from position  159 compared with the
transcriptional start site) was amplified using specific primers; this amplified
fragment was digested by XbaI and BamHI and cloned into pIR1 digested by the
same enzymes20,25. The null strain (DgrlRA::kn) transformed with pGY1 was
named GY2155.
GrlR–GrlAD complex structure determination. pETDuet1-grlR-grlAD plasmid
was transformed into E. coli BL21 cells and grown in defined M9 medium26
supplemented with 25mg l 1 L-SeMet at 37 C until the optical density reached
0.6 at 600 nm. A 1-litre culture was induced with 100mM isopropyl b-D-1-
thiogalactopyranoside and grown overnight at 20 C. Cells were then collected by
centrifugation and resuspended in 40ml of lysis buffer (50mM Tris-HCl (pH 7.0),
0.2M NaCl, 1% (w/v) Triton X-100, 5% (w/v) glycerol, 10mM b-mercaptoethanol)
with complete protease inhibitors (Roche Applied Science, Mannheim, Germany).
The GrlA–GrlRD complex was purified in two steps using Ni-NTA (Qiagen,
Valencia, CA, USA), followed by gel filtration (Superdex75, GE Healthcare). The
6His tag remained intact on GrlR. Drops containing 1 ml of protein solution
(7mgml 1) and 1 ml of reservoir solution were equilibrated by hanging-drop
vapour diffusion at 25 C. The best crystals were grown from 12% PEG 3350, 0.1M
sodium malonate pH 5 and 0.4M non-detergent sulphobetaines 201, with the
protein in 30mM Tris-HCl (pH 7.0), 200mM NaCl and 5% (w/v) glycerol. One
complex consisted of two GrlR and one GrlAD (2:1) molecule in the asymmetric
unit, which accounts for a Matthews coefficient of 2.40 Å3Da 1 (ref. 27),
corresponding to a solvent content of 49%. Crystals were cryoprotected in the
reservoir solution supplemented with 25% glycerol and flash cooled at 100 K.
The structure was determined using SeMet-labelled protein crystals by single-
wavelength anomalous dispersion28. X-ray diffraction data were collected at
beamline 13B1, National Synchrotron Radiation Research Centre (Taiwan), using a
Quantum-315r charge-coupled device area detector (ADSC) and processed with
HKL2000 (ref. 29). All of the expected eight Se sites of an asymmetric unit were
located using the programme Phenix-Autosol. The phases were further improved
by density modification using RESOLVE30, which gave a final overall figure of
merit of 0.70. Over 50% of the backbone atoms of the model were built by
RESOLVE. The remaining residues were manually built using COOT31 and refined
with phenix-refine32. Refinement was continued until the R-value converged to
0.18 (Rfree¼ 0.23) for reflections I4s (I) to 2.7 Å resolution (Table 1). The model
had good stereochemistry, with 99.3% residues falling within the allowed regions of
the Ramachandran plot. Subsequently, the importance of the key residues in the
HTH motif region was validated by structure-based in vitro studies, such as ITC
and pull-down assay (see Supplementary Methods).
Analytical ultracentrifugation. The stoichiometric ratio of WT GrlR–GrlA
complex was investigated by monitoring their sedimentation properties in sedi-
mentation velocity experiments. Samples (400 ml) were used at A280 nm of 1.0 in
30mM Tris-HCl (pH 7.0), 200mM NaCl and 5% glycerol. Sedimentation velocity
profiles were collected by monitoring the absorbance at 280 nm. The samples were
sedimented at 40,000 r.p.m. at 20 C in a Beckman Optima XL-I centrifuge
(Beckman Coulter Inc., Brea, CA, USA) fitted with a four-hole AN-60 rotor and
double-sector aluminium centre pieces, and equipped with absorbance optics. A
total of 200 scans were collected and analysed using the Sedfit programme33.
Circular dichroism spectrometry. Far ultraviolet spectra (260–190 nm) of MBP-
GrlA/MBP-GrlAD and its substituents were measured using a Jasco J-810 spec-
tropolarimeter (Jasco Europe, Milan, Italy) in phosphate buffer (pH 7.5) at room
temperature using a 0.1-cm path length and stoppered cuvettes. Six scans were
recorded, averaged and the baseline subtracted.
Isothermal titration calorimetry. MBP-GrlA, MBP-GrlAD (with or without
substitutions in the HTH motif region) and GrlR were all purified in gel filtration
buffer containing 30mM Tris-HCl (pH 7.0), 200mM NaCl and 5% glycerol. ITC
experiments were carried out using a VP-ITC calorimeter (Microcal, LLC,
Northampton, MA, USA) at 25 C using 0.01mM protein (MBP-GrlA/MBP-
GrlAD) in the sample cell and 0.15–0.22mM GrlR in the injector. All samples were
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thoroughly degassed and then centrifuged to remove precipitates. Excluding the
first 2-ml injection, 10-ml injections were sequentially made in each experiment.
Consecutive injections were separated by 5min to allow the peak to return to
baseline levels. ITC data were analysed with a model considering a single class of
binding sites implemented in Origin 7.0 (Origin Lab Corp., Northampton, MA,
USA) software.
Electrophoretic mobility shift assays. EMSA assays were performed by mixing
B100 ng of DNA (promoter region of ler ( 275/þ 217; numbers indicate the
number of base pairs upstream and downstream from the functional ATG start
codon, respectively), flhDC ( 455/þ 223) or ehxCABD ( 261/þ 22) with
increasing concentrations of purified WT or mutant MBP-GrlA proteins in binding
buffer containing 10mM Tris-HCl (pH 8), 50mM KCl, 1mM dithiothreitol,
0.5mM EDTA, 10mgml 1 BSA and 5% glycerol. The primers used to amplify the
promoter regions are shown in Supplementary Table S3. Reaction mixtures were
incubated for 30min at room temperature and then separated by electrophoresis
on 5% polyacrylamide gels in 0.5 Tris-borate–EDTA buffer. DNA bands were
stained with ethidium bromide and visualized with a Syngene transilluminator
(Syngene, Frederick, MD, USA). For competitive EMSA assays, DNA was incu-
bated with 1 mM MBP-GrlA for 30min, followed by the addition of increasing
concentrations of His-GrlR for an additional 30min at room temperature. The
complexes were visualized as described above. The formation of GrlR–GrlA
complex in the competitive EMSA assay was verified by setting up a 300-ml
amylose-resin-bound MBP-GrlA–DNA-binding reaction for 30min. A 30-ml
sample was run as input on EMSA assay and SDS–PAGE, and the rest was washed
several times with excess DNA-binding buffer before titrating with GrlR. A 30-ml
sample was run after titrating with GrlR followed by washes. The final beads and all
other washes along with the initial samples were analysed on both EMSA and SDS–
PAGE gels. All the EMSA studies were repeated three times and the results were
consistent.
Extracellular protein extraction and detection. Overnight cultures of EPEC
strains were grown in DMEM medium (Invitrogen, Carlsbad, CA, USA) and
supplemented with 30mgml 1 of kanamycin, 40 mgml 1 streptomycin and
34mgml 1 chloramphenicol until the optical density at 600 nm reached 0.8. The
cultures were diluted 1:50 into fresh DMEM medium and incubated for 9 h at 37 C
in a shaking water bath at 200 r.p.m. Bacterial cells were centrifuged at 5,500 g for
10min at 4 C and the supernatants were passed through a 0.22-mm filter (Millex,
Millipore). The extracellular protein fraction was isolated by trichloroacetic acid
precipitation and the protein pellet was washed thrice with  20 C acetone and
then air dried34. Extracellular protein pellets were solubilized in Ready Prep reagent
3 (5M urea, 2M thiourea, 2% (w/v) CHAPS, 2% (w/v) SB 3–10, 40mM Tris and
0.2% (w/v) Bio-Lyte 3/10 ampholyte (Bio-Rad, Hercules, CA, USA)), and stored at
 80 C, as described34. Proteins were transferred to a polyvinylidene difluoride
(PVDF) membrane. EspB was detected by the addition of diluted anti-EspB
(1:2,000) polyclonal antiserum, followed by a 1:5,000 dilution of mouse anti-rabbit
IgG horseradish peroxidase (1:5,000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA). The PVDF membrane was examined using the SuperSignal WestPico
Chemiluminescent substrate (Pierce Biotechnology; Rockford, IL, USA) under the
conditions recommended by the manufacturer.
ler-gfp Promoter assay. The plasmid pGY1 contains a transcriptional fusion of
the gfp to the ler gene and its regulatory region20. The plasmid was transformed
into the EPEC grlRA::kn mutant strain EM3715 to create strain GY2155. EPEC
strain GY2155 was then transformed with a compatible, pACYC184-based
plasmid, expressing GrlA or GrlAD and various grlA mutants. The constructed
strains were grown in DMEM overnight as described above. Cells were then
collected by centrifugation at 5,500 g for 10min at 4 C and resuspended in lysis
buffer (1 PBS) with complete protease inhibitors (Roche Applied Science). The
cells were lysed and centrifuged down at 30,000g for 30min. Protein concentrations
in the supernatant were adjusted and separated on an SDS–PAGE, transferred to a
PVDF membrane and subjected to western blotting. GFP was detected by the
addition of diluted anti-GFP (1:2,000) rabbit monoclonal antibody (Invitrogen),
followed by a 1:5,000 dilution of mouse anti-rabbit IgG horseradish peroxidase
(Santa Cruz Biotechnology). The PVDF membrane was examined using the
SuperSignal WestPico Chemiluminescent substrate under the conditions recom-
mended by the manufacturer.
References
1. Nataro, J. & Kaper, J. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11,
142–201 (1998).
2. Pennington, H. Escherichia coli O157. Lancet 376, 1428–1435 (2010).
3. Deng, W. et al. Dissecting virulence: systematic and functional analyses of a
pathogenicity island. Proc. Natl Acad. Sci. USA 101, 3597–3602 (2004).
4. Barba, J. et al. A positive regulatory loop controls expression of the locus of
enterocyte effacement-encoded regulators Ler and GrlA. J. Bacteriol. 187,
7918–7930 (2005).
5. Bustamante, V. H. et al. PerC and GrlA independently regulate Ler
expression in enteropathogenic Escherichia coli. Mol. Microbiol. 82, 398–415
(2011).
6. Iyoda, S. et al. The GrlR-GrlA regulatory system coordinately controls
the expression of flagellar and LEE-encoded type III protein secretion
systems in enterohemorrhagic Escherichia coli. J. Bacteriol. 188, 5682–5692
(2006).
7. Iyoda, S. & Watanabe, H. ClpXP protease controls expression of the type III
protein secretion system through regulation of RpoS and GrlR levels in
enterohemorrhagic Escherichia coli. J. Bacteriol. 187, 4086–4094 (2005).
8. Jobichen, C. et al. Structure of GrlR and the implication of its EDED motif in
mediating the regulation of type III secretion system in EHEC. PLoS Pathog. 3,
e69 (2007).
9. Jobichen, C. et al. Identification and characterization of the lipid-binding
property of GrlR, a locus of enterocyte effacement regulator. Biochem. J. 420,
191–199 (2009).
10. Jime´nez, R., Cruz-Migoni, S. B., Huerta-Saquero, A., Bustamante, V. H. &
Puente, J. L. Molecular characterization of GrlA, a specific positive regulator of
ler expression in enteropathogenic Escherichia coli. J. Bacteriol. 192, 4627–4642
(2010).
11. Kitagawa, R., Takaya, A. & Yamamoto, T. Dual regulatory pathways of flagellar
gene expression by ClpXP protease in enterohaemorrhagic Escherichia coli.
Microbiology 157, 3094–3103 (2011).
12. Fujita, Y. & Taguchi, H. Overview and outlook of Toll-like receptor ligand-
antigen conjugate vaccines. Ther. Deliv. 3, 749–760 (2012).
13. Deretic, V. Autophagy as an innate immunity paradigm: expanding the scope
and repertoire of pattern recognition receptors. Curr. Opin. Immunol. 24,
21–31 (2012).
14. Schmidt, H., Beutin, L. & Karch, H. Molecular analysis of the plasmid-encoded
hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63,
1055–1061 (1995).
15. Welch, R. A. & Pellett, S. Transcriptional organization of the Escherichia coli
hemolysin genes. J. Bacteriol. 170, 1622–1630 (1988).
16. Issartel, J. P., Koronakis, V. & Hughes, C. Activation of Escherichia coli
prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty
acylation. Nature 351, 759–761 (1991).
17. Wagner, W., Vogel, M. & Goebel, W. Transport of hemolysin across the outer
membrane of Escherichia coli requires two functions. J. Bacteriol. 154, 200–210
(1983).
18. Holm, L. & Sander, C. Touring protein fold space with Dali/FSSP. Nucleic Acids
Res. 26, 316–319 (1998).
19. Mellies, J., Elliott, S., Sperandio, V., Donnenberg, M. & Kaper, J. The Per
regulon of enteropathogenic Escherichia coli: identification of a regulatory
cascade and a novel transcriptional activator, the locus of enterocyte effacement
(LEE)-encoded regulator (Ler). Mol. Microbiol. 33, 296–306 (1999).
20. Yerushalmi, G., Nadler, C., Berdichevski, T. & Rosenshine, I. Mutational
analysis of the locus of enterocyte effacement-encoded regulator (Ler) of
enteropathogenic Escherichia coli. J. Bacteriol. 190, 7808–7818 (2008).
21. Saitoh, T. et al. Transcription of the ehx enterohemolysin gene is positively
regulated by GrlA, a global regulator encoded within the locus of enterocyte
effacement in enterohemorrhagic Escherichia coli. J. Bacteriol. 190, 4822–4830
(2008).
22. Hayward, R. D., Leong, J. M., Koronakis, V. & Campellone, K. G. Exploiting
pathogenic Escherichia coli to model transmembrane receptor signalling. Nat.
Rev. Microbiol. 4, 358–370 (2006).
23. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes
in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97,
6640–6645 (2000).
24. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R. Site-directed
mutagenesis by overlap extension using the polymerase chain reaction. Gene
77, 51–59 (1989).
25. Friedberg, D., Umanski, T., Fang, Y. & Rosenshine, I. Hierarchy in the
expression of the locus of enterocyte effacement genes of enteropathogenic
Escherichia coli. Mol. Microbiol. 34, 941–952 (1999).
26. Doublie´, S. Preparation of selenomethionyl proteins for phase determination.
Methods Enzymol. 276, 523–530 (1997).
27. Matthews, B. Solvent content of protein crystals. J. Mol. Biol. 33, 491–497
(1968).
28. Terwilliger, T. & Berendzen, J. Bayesian correlated MAD phasing. Acta
Crystallogr. D Biol. Crystallogr. 53, 571–579 (1997).
29. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in
oscillation mode. In Methods in Enzymology. Vol. 276, 307–326 (Academic
Press (1997).
30. Terwilliger, T. SOLVE and RESOLVE: automated structure solution and
density modification. Methods Enzymol. 374, 22–37 (2003).
31. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics.
Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3546 ARTICLE
NATURE COMMUNICATIONS | 4:2546 |DOI: 10.1038/ncomms3546 |www.nature.com/naturecommunications 9
& 2013 Macmillan Publishers Limited. All rights reserved.
32. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for
macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66,
213–221 (2010).
33. Schuck, P. Size-distribution analysis of macromolecules by sedimentation
velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78,
1606–1619 (2000).
34. Li, M. et al. Comparative proteomic analysis of extracellular proteins of
enterohemorrhagic and enteropathogenic Escherichia coli strains and their
ihf and ler mutants. Appl. Environ. Microbiol. 70, 5274–5282 (2004).
35. Delano, W. L. The PyMOL molecular graphics system.
http://pymol.sourceforge.net (2002).
Acknowledgements
This work was partially supported by a BMRC grant (WBS R154000461305) from the
Agency for Science Technology and Research (A*STAR), Singapore. We acknowledge the
National Synchrotron Radiation Research Centre beamline 13B1 of the Taiwan syn-
chrotron facility. I.R. was supported by a grant from the Israeli Science Foundation (ISF).
K.Y.L. was supported by a grant from the Natural Science and Engineering Research
Council (NSERC) Discovery Grant (372373-2010), Canada and Open Funding Project of
the State Key Laboratory of Bioreactor Engineering of China. We acknowledge the
assistance provided by Dr Gal Yerushalmi in plasmid construction. A.P. is a graduate
scholar in receipt of a research scholarship from the National University of Singapore
(NUS).
Author contributions
J.S. conceived and designed the study. A.P. performed cloning, expression, purification
crystallization, data collection and biophysical analysis. C.J. and A.P. performed the
crystallographic calculations and analysis. E.M. generated the null mutants and ler-gfp
plasmids. A.V.-C. analysed the ITC data. K.Y.L., Y.K.M. and L.M. were involved in the
analysis. A.P., C.J., I.R. and J.S. wrote the paper.
Additional information
Accession code: Coordinates of GrlR:GrlAD complex have been deposited in the Protein
Data Bank under accession code 4KT5.
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Padavannil, A. et al. Structure of GrlR–GrlA complex that
prevents GrlA activation of virulence genes. Nat. Commun. 4:2546 doi: 10.1038/
ncomms3546 (2013).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3546
10 NATURE COMMUNICATIONS | 4:2546 | DOI: 10.1038/ncomms3546 | www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
